Panel says Biogen's Aduhelm Alzheimer's drug shows no benefit
An expert panel unanimously voted that Biogen’s controversial Alzheimer’s drug does not provide more benefit to patients than supportive care.
FDA chief calls for investigation into Biogen Alzheimer's drug approval process
The Food and Drug Administration’s acting commissioner, Janet Woodcock, is taking the highly unusual step of asking for a federal investigation of doctors within her own agency who met with the makers of an Alzheimer’s drug prior to the medicine’s FDA approval.
FDA trims use of contentious Alzheimer's drug amid backlash
U.S. health regulators on Thursday approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer’s drug.
Theranos founder Elizabeth Holmes renews fight to constrain prosecutors
During a virtual hearing, Ms. Holmes’s lawyers and the U.S. attorney’s office in Northern California continued months of finger-pointing over who is to blame for the inability to access the blood-test database. Called the Laboratory Information System, it recorded data points on millions of Theranos blood tests but became inaccessible in 2018 under circumstances the prosecution and defense disagree about.
Can countries legally mandate citizens to get vaccinated?
Business law attorney Seth Berenzweig on the legal implications that come with potential government vaccine requirements.
J&J COVID-19 vaccine shows promising early signs of protecting against Delta variant
The new findings “reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help protect the health of people globally,” said J&J Chief Scientific Officer Paul Stoffels.
Walgreens administered 25M COVID-19 vaccines, sees pace slowing
Walgreens administered 25M COVID-19 vaccines and tells investors the pace will slow in the coming weeks and months.
Walmart launches low-cost private insulin for diabetes patients
Walmart has launched a private brand of analog insulin, the company announced Tuesday. The insulin injection, manufactured by Novo Nordisk, and FlexPen, offered through Walmart’s ReliOn brand, will be available in the stores' pharmacies this week.
Costly new Alzheimer's drug could force Medicare to restrict access
The recent approval of a high-price Alzheimer’s drug is raising questions about who will have access to a treatment that could cost Medicare billions of dollars in coming years.
Booster may be needed for J&J shot as Delta variant spreads
-Infectious disease experts are weighing the need for booster shots of the Pfizer/BioNTech or Moderna mRNA-based vaccines for Americans who received Johnson & Johnson's one-dose vaccine due to the increasing prevalence of the more contagious Delta coronavirus variant
Johnson & Johnson settles New York opioid case for $230 million
Johnson & Johnson has agreed to pay $230 million to the state of New York to resolve an opioid lawsuit slated to go to trial Tuesday, as negotiations intensify with the company and three drug distributors to clinch a $26 billion settlement of thousands of other lawsuits blaming the pharmaceutical industry for the opioid crisis.
FDA adds warning about rare heart inflammation to Pfizer, Moderna COVID vaccines
The Food and Drug Administration (FDA) on Friday added a warning to the literature that accompanies Pfizer Inc/BioNTech and Moderna COVID vaccine shots to indicate the rare risk of heart inflammation after its use.
Eli Lilly COVID-19 antibody drug shipments paused over variant concerns
U.S. health officials have paused the distribution of two Eli Lilly & Co. COVID-19 monoclonal antibody treatments because of data showing that they aren’t effective against virus variants that are becoming increasingly common across the country.
Substandard generic drugs are flooding the US market and putting all Americans at risk
Most Americans would be shocked to learn that millions of doses of poor-quality and potentially harmful generic drugs are being imported into the United States each year.
Michael Milken on COVID-19 vaccines, treatments: 'American science has won'
Financer and philanthropist Michael Milken weighed in on COVID-19 treatments during an exclusive interview with “Mornings with Maria” on Tuesday and argued that “American science has won.”
Medicaid enrollment surged during COVID-19 pandemic, report shows
More than 80 million people — a record number — have health coverage through Medicaid and the Children’s Health Insurance Program, as enrollments surged due to Covid-19, according to new data released Monday by the Centers for Medicare and Medicaid Services.
Georgia hospital system hit with ransomware attack following Biden-Putin summit
St. Joseph's/Candler, one of the largest hospital systems in Savannah, Georgia, confirmed it was hit with a ransomware attack on Thursday morning.
Apple struggles in push to make health care its greatest legacy
Apple Inc. chief executive Tim Cook has said the company’s greatest contribution to mankind will be in health. So far, some Apple initiatives aimed at broadly disrupting the health care sector have struggled to gain traction,
Nearly 6,000 USPS workers attacked by dogs in 2020
The carriers have faced anything from "nips and bites to vicious attacks," according to the government agency's annual report.
Novavax CEO: COVID-19 booster to be 'biggest market' in US
Novavax’s CEO said he believes boosters will be the company’s “biggest market” in the U.S. once it receives regulatory approval for its COVID-19 vaccine.
















